Concurrent Chemoradiotherapy Clinical Trials

13 clinical trials for Concurrent Chemoradiotherapy across international registries, including 4 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Combination of Concurrent Chemoradiotherapy With Surufatinib and Tislelizumab in Patients With Locally Advanced Non-Small Cell Lung Cancer — RECRUITING · PHASE2
• Neoadjuvant Immunotherapy Plus Chemotherapy Followed by Concurrent Chemoradiotherapy and Consolidative Immunotherapy for Locally Advanced Non-small Cell Lung Cancer — RECRUITING · PHASE3
• Neoadjuvant Chemoimmunotherapy Versus Concurrent Chemoradiotherapy for LACC — RECRUITING · PHASE2
• Concurrent Chemoradiotherapy Followed by PD-1 Inhibitor in Advanced Cervical Cancer — RECRUITING · PHASE1
• Chemoradiotherapy Following Immunotherapy Plus Chemotherapy for Locally-advanced Esophageal Squamous Cell Cancer (RICE) — ACTIVE_NOT_RECRUITING · PHASE2
• The Effect of Prophylactic TPO Combined with BMS-IMRT to Esophageal Cancer Patients — COMPLETED · PHASE2
• Efficacy and Safety of Concurrent PD-1 Inhibitor and Radiotherapy With Immunonutrition for Esophageal Squamous Cell Carcinoma — ACTIVE_NOT_RECRUITING · PHASE2
• the Predictive Value of Immune Cell in Locally Advanced Cervical Cancer — OTHER
• Optimized Treatment Strategies for Early and Medium Stage Nasopharyngeal Carcinoma — OTHER · PHASE2
• NAC Followed by RH for the Treatment of LACC — OTHER · PHASE2
• Neoadjuvant Chemotherapy Followed by Preoperative Chemoradiation in Resectable Squamous-cell Esophageal Cancer — OTHER · PHASE2
• CCRT for Esophageal Cancer. — COMPLETED · PHASE2
• Combination of Nimotuzumab,Capecitabine and Radiotherapy for Inoperable or Recurrent Gastric Cancer — OTHER · PHASE2

Refine this search